老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ALPS Medical Breakthroughs ETF
62.20
-1.5276
-2.40%
盤後:
62.12
-0.0806
-0.13%
19:30 EDT
成交量:
1.95萬
成交額:
121.45萬
市值:
2.25億
市盈率:
- -
高:
63.39
開:
63.10
低:
61.96
收:
63.73
52周最高:
70.85
52周最低:
36.32
股本:
362.50萬
流通股本:
362.50萬
量比:
0.41
換手率:
0.54%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
創新藥研發加速遇「猴荒」
三里河
·
07/22
ANI Pharmaceuticals 宣佈擬就CG Oncology相關裁決提出上訴
投资观察
·
07/17
英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作
新浪港股
·
07/13
(活力中國調研行)上海生物醫藥產業規模破萬億 張江藥谷青年人才成創新藥研發主力
中国新闻网
·
07/08
翰思艾泰-B(03378):擬與華科前沿交叉研究中心打造新一代AI驅動的創新藥研發範式
智通财经
·
07/07
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/SBIO/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":62.2006,"timestamp":1789761600000,"preClose":63.7282,"halted":0,"volume":19490,"hourTrading":{"tag":"盘后","latestPrice":62.12,"preClose":62.2006,"latestTime":"19:30 EDT","volume":18,"amount":1107.3954,"timestamp":1789774205561,"change":-0.0806,"changeRate":-0.001296,"amplitude":0},"delay":0,"changeRate":-0.023970549929230697,"floatShares":3625000,"shares":3625000,"eps":0,"marketStatus":"休市中","change":-1.5276,"latestTime":"09-18 16:00:00 EDT","open":63.1,"high":63.385,"low":61.96,"amount":1214539.54164,"amplitude":0.022361,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":63.7282,"sharesOutstanding":2675000,"nav":62.25,"aum":225655960.35,"bidAskSpread":0.002808,"postHourTrading":{"tag":"盘后","latestPrice":62.12,"preClose":62.2006,"latestTime":"19:30 EDT","volume":18,"amount":1107.3954,"timestamp":1789774205561,"change":-0.0806,"changeRate":-0.001296,"amplitude":0},"volumeRatio":0.4133107687792956,"impliedVol":0.2645,"impliedVolPercentile":0.8446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3625000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4133107687792956,"shares":3625000,"dividePrice":0,"high":63.385,"amplitude":0.022361,"preClose":63.7282,"low":61.96,"week52Low":36.32,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":62.2006,"eps":0,"divideRate":0,"volume":19490,"delay":0,"ttmEps":0,"open":63.1,"prevYearClose":51.22,"prevWeekClose":63.29,"prevMonthClose":66.82,"prevQuarterClose":64.65,"fiveDayClose":63.29,"twentyDayClose":68.56,"sixtyDayClose":60.843},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653584157","title":"創新藥研發加速遇「猴荒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里,不要像猴子一样站在那里。”资本市场从来不缺故事。近期,昭衍新药业绩暴增,原因是实验猴市场价格上涨,带动公司手里的“猴子资产”大幅增值,多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜,挖出了“香蕉概念”。网友戏称:这是产业链挖掘最深的一次。一只猴子,为什么能扰动资本市场?答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBB","BK4588","WRND","GDOC","BBP","BK4585","XLVI","SBIO","GSKH","LFSC","PBE","BIOY","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196709641","title":"ANI Pharmaceuticals 宣佈擬就CG Oncology相關裁決提出上訴","url":"https://stock-news.laohu8.com/highlight/detail?id=1196709641","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196709641?lang=zh_tw&edition=fundamental","pubTime":"2026-07-17 06:34","pubTimestamp":1784241277,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals Inc. 宣布,计划就与CG Oncology Inc.相关诉讼中的裁决提出上诉。此前,初审法院已驳回该公司提出的重新审理及判决的动议。\n该公司表示,将继续寻求追回其在2010年出售给CG Oncology的资产价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139","LU1559883803.SGD","SBIO","BK4007","LU0566484027.USD","ANIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162210","title":"英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162210?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 10:02","pubTimestamp":1783908120,"startTime":"0","endTime":"0","summary":" 英硅智能早盘涨超7%,截至发稿,股价上涨6.21%,报45.48港元,成交额3.32亿港元。 7月13日,据英硅智能官微消息,公司宣布与康哲药业在中枢神经系统领域开展另一项AI驱动的药物发现合作。 根据合作协议,双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力,以及康哲药业经验丰富的研发团队和对疾病领域的深度认知,双方共同推进该研发项目的合作开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GSKH","IE00BVYPNQ40.USD","AIPO","ARTY","IE00BVYPNP33.GBP","00867","SBIO","SG9999015952.SGD","QTOC","BK4585","BK1191","IBB","VTHR","SG9999015945.SGD","WRND","AGIX","BK1593","SG9999015978.USD","CHAT","GDOC","LFSC","LU2488822045.USD","PBE","IE00BGHQDM52.EUR","BBP","BK4588","SG9999015986.USD","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649952006","title":"(活力中國調研行)上海生物醫藥產業規模破萬億 張江藥谷青年人才成創新藥研發主力","url":"https://stock-news.laohu8.com/highlight/detail?id=2649952006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649952006?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 11:56","pubTimestamp":1783482969,"startTime":"0","endTime":"0","summary":"中新网上海7月8日电(杨海燕马佳佳)“我们对青年人才‘如饥似渴’,上海团队有180多名全职员工,90%以上都是40岁以下的青年人才。”英硅智能全球对外合作负责人、副总裁王珏7日在“活力中国调研行”主题采访活动中介绍道。在上海张江药谷,这片曾经的农田已崛起为世界级生物医药创新高地,而活跃其中的青年人才,正成为推动创新药研发的主力军。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798154946.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798154946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","IBB","GSKH","PBE","161726","BBP","BK4588","BK4585","GDOC","LFSC","SBIO","WRND","BK4581","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984355","title":"翰思艾泰-B(03378):擬與華科前沿交叉研究中心打造新一代AI驅動的創新藥研發範式","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984355","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984355?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 18:57","pubTimestamp":1783421872,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰思艾泰-B 发布公告,为充分发挥产学研结合的优势,加速生物医药研发创新,公司于近日与华科—澳城大高等研究院前沿交叉研究中心正式签署了《“人工智能药物研发联合实验室”合作共建协议》。双方将依托华科前沿交叉研究中心的AI平台,以及翰思艾泰在创新药研发的丰富经验和对疾病领域的深度认知,围绕抗体发现与分子设计展开深度合作,共同打造新一代AI驱动的创新药研发范式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LFSC","CHAT","GDOC","AGIX","ARTY","BK1161","BK1173","GSKH","QTOC","BBP","PBE","SBIO","WRND","BK4588","BK1535","VTHR","IBB","BK4585","AIPO","03378"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":25,"code":"91000000","status":"200"}]}}